Evidence map›Paper›PMID 41948390›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Homogeneous shear distribution improves NK-92 cell cytotoxicity in a clinically relevant 2 L membrane-stirred bioreactor.

Valentin von Werz, Yasemin van Heuvel, Matthias Hadrbolec, Michael Wagner, Philipp Eibl, Florian Huber, Moritz Meyer, Patrick Bongartz, Christian Witz, Oliver Spadiut

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Valentin von WerzResearch Division Integrated Bioprocess Development, Institute of Chemical, Environmental and Bioscience Engineering, Technische Universität, Wien, Austria.
Yasemin van HeuvelBioThrust GmbH, Aachen, Germany.
Matthias HadrbolecResearch Division Integrated Bioprocess Development, Institute of Chemical, Environmental and Bioscience Engineering, Technische Universität, Wien, Austria.
Michael WagnerSimVantage GmbH, Graz, Austria.
Philipp EiblSimVantage GmbH, Graz, Austria.
Florian HuberBioThrust GmbH, Aachen, Germany.
Moritz MeyerBioThrust GmbH, Aachen, Germany.
Patrick BongartzBioThrust GmbH, Aachen, Germany.
Christian WitzSimVantage GmbH, Graz, Austria.
Oliver SpadiutResearch Division Integrated Bioprocess Development, Institute of Chemical, Environmental and Bioscience Engineering, Technische Universität, Wien, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immortalized NK-92 cell line is widely used to study natural killer (NK) cell biology and develop immunotherapies. NK-92 cells exhibit strong cytotoxic activity against tumor and virus-infected cells and are often used as a functional surrogate for primary NK cells. Beyond research applications, NK-92 cells are currently being evaluated in clinical trials as an allogeneic, off-the-shelf cell therapy. NK cells are typically cultured in static systems, which limits scalability. For clinical and commercial applications, large-scale cell expansion requires scalable platforms, such as bioreactors. However, conventional bubble-aerated bioreactors generate shear stress and foam, which can impair proliferation during prolonged culture and compromise cell quality. To address these limitations, a membrane-based stirring and aeration system was compared to a conventional pitched-blade impeller with microsparger aeration in 2 L stirred-tank bioreactors. NK-92 cells were expanded from static pre-cultures into shake flasks and subsequently inoculated into each bioreactor with continuous feeding to maintain ideal nutrient supply. Both systems supported comparable growth, viability, and metabolic profiles. Cells showed comparable growth, viability and metabolism profile in both systems. However, cells expanded in the membrane-based system exhibited markedly higher cytotoxicity and cytotoxic capacity. Computational fluid dynamic simulations of both systems suggest that this observation is likely attributable to the more homogeneous shear distribution in the membrane-stirred setup compared to the pitched-blade configuration. Overall, this work presents a novel cultivation method to produce highly cytotoxic NK-92 cells in a well scalable stirred-tank bioreactor platform for allogeneic off-the-shelf cell therapy.

Indexed as

bioreactorcomputational fluid dynamicscytotoxicityfed-batchmembrane stirrerNK-92pitched-bladeshear force

Identifiers

PMID41948390
PMCPMC13050783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.